• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ALINITY C CALCIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ALINITY C CALCIUM Back to Search Results
Catalog Number 07P57-20
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/18/2019
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.Patient identifier: complete entry is (b)(6).An evaluation is in process.A final report will be submitted when the evaluation is complete.
 
Event Description
The customer reported falsely elevated alinity c calcium results across three alinity c analyzers.The customer indicated they use a therapeutic range of less than or equal to 2.85 mmol/l the following results were provided: sample id (b)(6): generated results of 3.51, 3.52 and 2.97 mmol/l across three, alinity analyzers.Following recentrifuge 2.91, 2.90 and 2.85 mmol/l, second sample: generated 2.85, 2.71, 2.76 and 2.79 mmol/l, no impact to patient management was reported.
 
Manufacturer Narrative
The reagent lot was provided and section d suspect medical device, cataloge #, lot # and udi # fields were updated to reflect this change.No other corrections were required.Review of complaint activity for lot 6032un18 identified four other complaints for this customer documenting the current complaint issue.Aside from the current issue an increase in complaint activity was not identified.Tracking and trending report review for the alinity c calcium assay did not identify any trends.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the alinity c calcium assay was identified.
 
Manufacturer Narrative
The reagent was corrected to 07p57-20 and section d4 cataloge # and udi # fields were updated to reflect this change.No other corrections were required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C CALCIUM
Type of Device
CALCIUM
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key8927390
MDR Text Key189349241
Report Number3002809144-2019-00526
Device Sequence Number1
Product Code CJY
UDI-Device Identifier00380740132613
UDI-Public00380740132613
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 09/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/11/2019
Device Catalogue Number07P57-20
Device Lot Number63032UN18
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/30/2019
Initial Date FDA Received08/23/2019
Supplement Dates Manufacturer Received09/06/2019
09/20/2019
Supplement Dates FDA Received09/18/2019
09/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY C PROCESSING MODULE, LIST 03R67-01,; ALINITY C PROCESSING MODULE, LIST 03R67-01,; ALINITY C PROCESSING MODULE, LIST 03R67-01,; SERIAL AC01873, AC01872 AND AC01401; SERIAL AC01873, AC01872 AND AC01401; SERIAL AC01873, AC01872 AND AC01401
-
-